| Riza Rana, PHARMD | |
|
2101 S St, Sacramento, CA 95816-7101 | |
| (916) 731-4470 | |
| Not Available |
| Full Name | Riza Rana |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 2101 S St, Sacramento, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114473022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P2201X | Pharmacist - Ambulatory Care | 74739 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Riza Rana, PHARMD 7405 Greenback Ln # 161, Citrus Heights, CA 95610-5653 Ph: () - | Riza Rana, PHARMD 2101 S St, Sacramento, CA 95816-7101 Ph: (916) 731-4470 |
News Archive
Biomaterials are substances, natural or manmade, that are used in medicine to interact with the human body for various purposes, such as wound healing and tissue regeneration.
Controlling HIV/AIDS in India is an "immense" challenge for the country's National AIDS Control Organization - which is preparing to launch on April 1 the third phase of its National AIDS Control Program, a new five-year, $2.6 billion program that aims to reduce the number of new HIV cases and improve access to treatment in the country - NEJM national correspondent Robert Steinbrook writes in a perspective piece.
The Boston Globe reports on the dramatic and fearful response to a "seemingly prosaic piece" of pending Massachusetts state legislation "that aims to better define - and, in some respects, restrict - the emergency powers of the state's public health officials."
Can treating depression in patients with heart failure help them live longer? That's one of the questions that University of Pittsburgh researchers hope to answer with a new five-year, $7.3 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH).
Oncolytics Biotech Inc. today announced that enrollment has been completed in a randomized Phase II study of REOLYSIN in patients with recurrent or metastatic castration resistant prostate cancer (IND 209). The trial is being sponsored and conducted by the NCIC Clinical Trials Group (NCIC CTG) at Queen's University in Kingston, Ontario.
› Verified 8 days ago
Dr. Gina Maria Warren, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Broadway, Coumadin Clinic, Sacramento, CA 95820 Phone: 916-335-8818 | |
Dr. John Sung, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2825 Capitol Ave, Sacramento, CA 95816 Phone: 916-887-0350 | |
Mr. Gerald Lee Freitas I, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8364 Rovana Cir, Sacramento, CA 95828 Phone: 916-379-1657 Fax: 916-379-1691 | |
Michele Ang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3521 Del Paso Rd, Sacramento, CA 95835 Phone: 951-310-0758 | |
Colette Newman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4650 Natomas Blvd, Sacramento, CA 95835 Phone: 916-419-6644 Fax: 916-419-4764 | |
Dr. Anh Minh Phan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6051 Florin Rd, Sacramento, CA 95823 Phone: 916-427-9731 | |
Dr. Joyce He, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8241 E Stockton Blvd, Pharmacy Administration, Sacramento, CA 95828 Phone: 916-525-6900 |